Are you Dr. Rademaker?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 43 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-2000
Summary
- Dr. Jurgen Rademaker, MD is a board certified radiologist in New York, New York. He is currently licensed to practice medicine in New York, New Jersey, and California. He is affiliated with Memorial Sloan Kettering Cancer Center and is an Associate Professor at Weill Cornell Medical College.
Education & Training
- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1994 - 1997
- Univ Luebeck- Med SchClass of 1991
Certifications & Licensure
- CA State Medical License 2002 - 2026
- NY State Medical License 2010 - 2026
- NJ State Medical License 2006 - 2025
- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 69 citationsPhase II biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas.Alison J. Moskowitz, Paola Ghione, Eric D. Jacobsen, Jia Ruan, Jonathan H. Schatz
Blood. 2021-10-19 - 11 citationsPhase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring.Caitlin Stewart, Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols
Clinical Cancer Research. 2021-10-06 - 17 citationsRomidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohortsNeha Mehta-Shah, Matthew A. Lunning, Alison J. Moskowitz, Adam M. Boruchov, Jia Ruan
American Journal of Hematology. 2021-07-12